Cairo – Mubasher: Kahira Pharmaceuticals reported net profits of EGP 113.8 million in fiscal year 2019/2020, up by 33.6% year-on-year (YoY) from EGP 85.17 million, the company's unaudited financial results showed.
The company’s sales rose to EGP 1 billion in the 12-month period ended on 30 June from EGP 957.6 million a year earlier, according to a bourse disclosure on Monday.
Over the first nine months of FY19/20, Kahira Pharmaceuticals achieved net profits of EGP 92.22 million, up from EGP 72.22 million in the year-ago period.
